Love the chart - weekly volume decreasing as sellers start to become less willing to part with the stock. So finally just bought a stack - market has nearly forgotten about Nextstellis.
I'm sure that will sell super well assuming FDA approval comes through, as it is the same hormone produced during pregnancy. Can't get a better "natural" sales pitch than that. I suspect the market will start to get excited about it at some stage soon, maybe even after the results update.
The women's health strategy can work - it just needs a killer product IMO, to provide a bit of leverage and brand recognition. Far better than street-fighting with other pure generics brands.
Look out Merck! Have provided an old link that might give some idea of potential revenues, and 25% NPAT margins???
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)